Macrophages come to mind as keys to cognitive decline

Journal of Clinical Investigation

Volumn 126, Issue 12, 2016, Pages 4393-4395

  Harrison, D G ^a   Guzik, Tomasz J ^b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; COGNITIVE DEFECT; ENDOTHELIAL DYSFUNCTION; HYPERTENSION; MACROPHAGE; MULTIINFARCT DEMENTIA; PERIVASCULAR MACROPHAGE; PRIORITY JOURNAL; REVIEW; SODIUM RETENTION; VASOCONSTRICTION; ANIMAL; COGNITIVE DYSFUNCTION; COMPLICATION; DEMENTIA, VASCULAR; HUMAN; IMMUNOLOGY; PATHOLOGY;

ANGIOTENSIN II; ANIMALS; BLOOD-BRAIN BARRIER; COGNITIVE DYSFUNCTION; DEMENTIA, VASCULAR; HUMANS; HYPERTENSION; MACROPHAGES;

EID: 85002590897     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI91277     Document Type: Review

References (19)

1. Launer LJ, Masaki K, Petrovitch H, Foley D, Hav-lik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995;274(23):1846-1851.
2. Ninomiya T, et al. Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension. 2011;58(1):22-28.
3. Richmond R, Law J, Kay-Lambkin F. Higher blood pressure associated with higher cognition and functionality among centenarians in Austra-lia. Am J Hypertens. 2011;24(3):299-303.
4. Corriveau RA, et al. The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline. Cell Mol Neurobiol. 2016;36(2):281-288.
5. Bueche CZ, et al. Hypertension drives parenchy-mal β-amyloid accumulation in the brain parenchyma. Ann Clin Transl Neurol. 2014;1(2):124-129.
6. Liu J, et al. Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology. Sci Rep. 2015;5:12059.
7. Haase N, et al. Amyloid-β peptides activate α1-adrenergic cardiovascular receptors. Hyper-tension. 2013;62(5):966-972.
8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74(6):1141-1148.
9. Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 2009;93(3):621-635.
10. Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 2006;100(1):328-335.
11. Wang HD, et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res. 1998;82(7):810-818.
12. Guzik TJ, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204(10):2449-2460.
13. Madhur MS, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2010;55(2):500-507.
14. Mikolajczyk TP, et al. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vas-cular dysfunction in hypertension. FASEB J. 2016;30(5):1987-1999.
15. Faraco G, et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Invest. 2016;126(12):4674-4689.
16. Schultze JL, Freeman T, Hume DA, Latz E. A tran-scriptional perspective on human macrophage biology. Semin Immunol. 2015;27(1):44-50.
17. Ongali B, et al. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebro-vascular, neuropathological and cognitive deficits in an Alzheimer's disease model. Neurobiol Dis. 2014;68:126-136.
18. Coca A. Hypertension and vascular dementia in the elderly: the potential role of anti-hypertensive agents. Curr Med Res Opin. 2013;29(9):1045-1054.
19. Davies SS, et al. Treatment with a γ-ketoal-dehyde scavenger prevents working memory deficits in hApoE4 mice. J Alzheimers Dis. 2011;27(1):49-59.